Neonatologists are using much less dexamethasone

E. S. Shinwell; M. Karplus; D. Bader; S. Dollberg; I. Gur; Z. Weintraub; S. Arnon; E. Gottfreid; A. Zaritsky; I. R. Makhoul; D. Reich; L. Sirota; I. Berger; A. Kogan; S. Yurman; M. Goldberg; D. Kohelet

doi:10.1136/fn.88.5.f432

Neonatologists are using much less dexamethasone

E. S. Shinwell
, M. Karplus
, D. Bader
, S. Dollberg
, I. Gur
, Z. Weintraub
, S. Arnon
, E. Gottfreid
, A. Zaritsky
, I. R. Makhoul
, D. Reich
, L. Sirota
, I. Berger
, A. Kogan
, S. Yurman
, M. Goldberg
, D. Kohelet

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality fell from 21% to 15% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.

Original language	English
Pages (from-to)	F432-F433
Journal	Archives of Disease in Childhood: Fetal and Neonatal Edition
Volume	88
Issue number	5
DOIs	https://doi.org/10.1136/fn.88.5.f432
State	Published - Sep 2003
Externally published	Yes

Access to Document

10.1136/fn.88.5.f432

Cite this

Shinwell, E. S., Karplus, M., Bader, D., Dollberg, S., Gur, I., Weintraub, Z., Arnon, S., Gottfreid, E., Zaritsky, A., Makhoul, I. R., Reich, D., Sirota, L., Berger, I., Kogan, A., Yurman, S., Goldberg, M., & Kohelet, D. (2003). Neonatologists are using much less dexamethasone. Archives of Disease in Childhood: Fetal and Neonatal Edition, 88(5), F432-F433. https://doi.org/10.1136/fn.88.5.f432

@article{2a866c9947bb4451b4244b37caed368d,

title = "Neonatologists are using much less dexamethasone",

abstract = "Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22\% to 6\%. Chronic lung disease in survivors rose slightly from 13\% to 17\%, and mortality fell from 21\% to 15\% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.",

author = "Shinwell, \{E. S.\} and M. Karplus and D. Bader and S. Dollberg and I. Gur and Z. Weintraub and S. Arnon and E. Gottfreid and A. Zaritsky and Makhoul, \{I. R.\} and D. Reich and L. Sirota and I. Berger and A. Kogan and S. Yurman and M. Goldberg and D. Kohelet",

year = "2003",

month = sep,

doi = "10.1136/fn.88.5.f432",

language = "אנגלית",

volume = "88",

pages = "F432--F433",

journal = "Archives of Disease in Childhood: Fetal and Neonatal Edition",

issn = "0003-9888",

publisher = "BMJ Publishing Group",

number = "5",

}

Shinwell, ES, Karplus, M, Bader, D, Dollberg, S, Gur, I, Weintraub, Z, Arnon, S, Gottfreid, E, Zaritsky, A, Makhoul, IR, Reich, D, Sirota, L, Berger, I, Kogan, A, Yurman, S, Goldberg, M & Kohelet, D 2003, 'Neonatologists are using much less dexamethasone', Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 88, no. 5, pp. F432-F433. https://doi.org/10.1136/fn.88.5.f432

TY - JOUR

T1 - Neonatologists are using much less dexamethasone

AU - Shinwell, E. S.

AU - Karplus, M.

AU - Bader, D.

AU - Dollberg, S.

AU - Gur, I.

AU - Weintraub, Z.

AU - Arnon, S.

AU - Gottfreid, E.

AU - Zaritsky, A.

AU - Makhoul, I. R.

AU - Reich, D.

AU - Sirota, L.

AU - Berger, I.

AU - Kogan, A.

AU - Yurman, S.

AU - Goldberg, M.

AU - Kohelet, D.

PY - 2003/9

Y1 - 2003/9

N2 - Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality fell from 21% to 15% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.

AB - Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality fell from 21% to 15% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.

UR - https://www.scopus.com/pages/publications/0042762743

U2 - 10.1136/fn.88.5.f432

DO - 10.1136/fn.88.5.f432

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 12937052

AN - SCOPUS:0042762743

SN - 0003-9888

VL - 88

SP - F432-F433

JO - Archives of Disease in Childhood: Fetal and Neonatal Edition

JF - Archives of Disease in Childhood: Fetal and Neonatal Edition

IS - 5

ER -

Neonatologists are using much less dexamethasone

Abstract

Access to Document

Other files and links

Fingerprint

Cite this